Researchers evaluated the effect of anti-acid treatment on disease progression in systemic sclerosis interstitial lung disease.
In a study of lenabasum treatment in systemic sclerosis, researchers evaluated variability of immunosuppressive therapy by geographic region; includes Q&A with study lead author, Dr Christopher Denton.
The FDA has granted Orphan Drug designation to TLY012 for the treatment of systemic sclerosis.
In this perspective, Tracy M. Frech, MD, MS, discusses the diagnosis and management of systemic sclerosis.
Lung ultrasound B-lines can depict modifications in the lung parenchyma of patients with systemic sclerosis and may be an independent predictor of additional pulmonary deterioration in individuals with the disease.
Using skin biopsy samples, the researchers identified biomarkers and pathways associated with systemic sclerosis pathogenesis.
Between one-fifth and one-third of patients with rheumatoid arthritis, connective tissue disease, and vasculitis have ocular complications.
The World Scleroderma Foundation developed preliminary guidance based on clinical questions on the SARS-CoV-2 infection for systemic sclerosis management during COVID-19.
Researchers evaluated the association between systemic sclerosis (SSc) and ischemic stroke, and determined risk factors for cerebrovascular accidents in SSc.
Researchers identified physical activity barriers and facilitators among patients with scleroderma.